Daewoong, Pharmaceuticals

Daewoong Pharmaceutical's Bersiporocin Receives 'Orphan Drug Designation' in Europe to Treat Idiopathic Pulmonary Fibrosis

07.08.2025 - 18:03:58 | prnewswire.co.uk

Daewoong Pharmaceutical Co., Ltd. Europe South Korea

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/daewoong-pharmaceuticals-bersiporocin-receives-orphan-drug-designation-in-europe-to-treat-idiopathic-pulmonary-fibrosis-302046478.html

en | boerse | 67990616 |